US Stock MarketDetailed Quotes

Immuneering (IMRX)

Watchlist
  • 5.410
  • -0.290-5.09%
Close Apr 14 16:00 ET
  • 5.430
  • +0.020+0.37%
Post 19:57 ET
349.77MMarket Cap-4.26P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immuneering (IMRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-7.33%59.38M
-25.90%13.75M
0.69%15.38M
-1.04%14.76M
1.04%15.49M
9.69%64.07M
13.84%18.56M
9.68%15.27M
10.43%14.91M
4.98%15.33M
Selling and administrative expenses
7.59%17.3M
21.55%4.49M
12.23%4.51M
0.99%4.3M
-2.67%4.01M
-4.07%16.08M
-15.76%3.69M
3.75%4.01M
5.17%4.25M
-6.05%4.12M
-General and administrative expense
7.59%17.3M
21.55%4.49M
12.23%4.51M
0.99%4.3M
-2.67%4.01M
-4.07%16.08M
-15.76%3.69M
3.75%4.01M
5.17%4.25M
-6.05%4.12M
Research and development costs
-12.33%42.05M
-37.71%9.25M
-3.42%10.87M
-1.86%10.45M
2.40%11.47M
15.23%47.96M
24.74%14.86M
11.97%11.25M
12.69%10.65M
9.71%11.2M
Depreciation amortization depletion
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
-Depreciation and amortization
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%29.27K
0.00%7.32K
0.00%7.32K
0.00%7.32K
0.00%7.32K
Operating profit
7.33%-59.38M
25.90%-13.75M
-0.69%-15.38M
1.04%-14.76M
-1.04%-15.49M
-9.69%-64.07M
-13.84%-18.56M
-9.68%-15.27M
-10.43%-14.91M
-4.98%-15.33M
Net non-operating interest income expense
17.20%3.04M
348.19%1.86M
-23.99%415.83K
-60.78%324.01K
-45.52%438.52K
-28.10%2.59M
-44.94%415.24K
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
Non-operating interest income
17.20%3.04M
348.19%1.86M
-23.99%415.83K
-60.78%324.01K
-45.52%438.52K
-28.10%2.59M
-44.94%415.24K
-36.05%547.07K
-29.15%826.1K
-3.17%804.88K
Other net income (expense)
-29.41%311.67K
-66.91%441.49K
-80.31%91.43K
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
Other non- operating income (expenses)
-29.41%311.67K
----
----
----
----
-66.91%441.49K
-80.31%91.43K
-72.81%129.31K
-94.86%7.72K
-12.74%213.04K
Income before tax
8.21%-56.02M
35.86%-11.58M
-2.51%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
Income tax
Net income
8.21%-56.02M
35.86%-11.58M
-2.51%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
Net income continuous Operations
8.21%-56.02M
35.86%-11.58M
-2.51%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.51%-14.08M
-5.80%-14.31M
Minority interest income
Net income attributable to the parent company
8.21%-56.02M
35.85%-11.58M
-2.52%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.21%-56.02M
35.85%-11.58M
-2.52%-14.96M
-2.51%-14.43M
-5.16%-15.05M
-14.15%-61.04M
-19.68%-18.05M
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
Basic earnings per share
37.75%-1.27
68.97%-0.18
22.45%-0.38
14.89%-0.4
14.29%-0.42
-8.51%-2.04
-11.54%-0.58
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
Diluted earnings per share
37.75%-1.27
68.97%-0.18
22.45%-0.38
14.89%-0.4
14.29%-0.42
-8.51%-2.04
-11.54%-0.58
-13.95%-0.49
-9.30%-0.47
3.92%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -7.33%59.38M-25.90%13.75M0.69%15.38M-1.04%14.76M1.04%15.49M9.69%64.07M13.84%18.56M9.68%15.27M10.43%14.91M4.98%15.33M
Selling and administrative expenses 7.59%17.3M21.55%4.49M12.23%4.51M0.99%4.3M-2.67%4.01M-4.07%16.08M-15.76%3.69M3.75%4.01M5.17%4.25M-6.05%4.12M
-General and administrative expense 7.59%17.3M21.55%4.49M12.23%4.51M0.99%4.3M-2.67%4.01M-4.07%16.08M-15.76%3.69M3.75%4.01M5.17%4.25M-6.05%4.12M
Research and development costs -12.33%42.05M-37.71%9.25M-3.42%10.87M-1.86%10.45M2.40%11.47M15.23%47.96M24.74%14.86M11.97%11.25M12.69%10.65M9.71%11.2M
Depreciation amortization depletion 0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K
-Depreciation and amortization 0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K0.00%29.27K0.00%7.32K0.00%7.32K0.00%7.32K0.00%7.32K
Operating profit 7.33%-59.38M25.90%-13.75M-0.69%-15.38M1.04%-14.76M-1.04%-15.49M-9.69%-64.07M-13.84%-18.56M-9.68%-15.27M-10.43%-14.91M-4.98%-15.33M
Net non-operating interest income expense 17.20%3.04M348.19%1.86M-23.99%415.83K-60.78%324.01K-45.52%438.52K-28.10%2.59M-44.94%415.24K-36.05%547.07K-29.15%826.1K-3.17%804.88K
Non-operating interest income 17.20%3.04M348.19%1.86M-23.99%415.83K-60.78%324.01K-45.52%438.52K-28.10%2.59M-44.94%415.24K-36.05%547.07K-29.15%826.1K-3.17%804.88K
Other net income (expense) -29.41%311.67K-66.91%441.49K-80.31%91.43K-72.81%129.31K-94.86%7.72K-12.74%213.04K
Other non- operating income (expenses) -29.41%311.67K-----------------66.91%441.49K-80.31%91.43K-72.81%129.31K-94.86%7.72K-12.74%213.04K
Income before tax 8.21%-56.02M35.86%-11.58M-2.51%-14.96M-2.51%-14.43M-5.16%-15.05M-14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M
Income tax
Net income 8.21%-56.02M35.86%-11.58M-2.51%-14.96M-2.51%-14.43M-5.16%-15.05M-14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M
Net income continuous Operations 8.21%-56.02M35.86%-11.58M-2.51%-14.96M-2.51%-14.43M-5.16%-15.05M-14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.51%-14.08M-5.80%-14.31M
Minority interest income
Net income attributable to the parent company 8.21%-56.02M35.85%-11.58M-2.52%-14.96M-2.51%-14.43M-5.16%-15.05M-14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.21%-56.02M35.85%-11.58M-2.52%-14.96M-2.51%-14.43M-5.16%-15.05M-14.15%-61.04M-19.68%-18.05M-15.90%-14.6M-15.52%-14.08M-5.17%-14.31M
Basic earnings per share 37.75%-1.2768.97%-0.1822.45%-0.3814.89%-0.414.29%-0.42-8.51%-2.04-11.54%-0.58-13.95%-0.49-9.30%-0.473.92%-0.49
Diluted earnings per share 37.75%-1.2768.97%-0.1822.45%-0.3814.89%-0.414.29%-0.42-8.51%-2.04-11.54%-0.58-13.95%-0.49-9.30%-0.473.92%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -